The Frontier Alternatives Map: Pre-IPO Names We Track vs. Newchip Warrants We Hold

AdValorem Research

As private-market valuations reflate and secondary markets deepen, we have found it useful to separate our Frontier Alternatives research work into two distinct buckets: (1) pre-IPO names we track and evaluate, and (2) equity warrants we hold via the Newchip portfolio. This distinction is more than taxonomy. It drives how we source information, how we interpret price signals, and how we translate company-level updates into a portfolio-level view of risk, liquidity, and opportunity.

This note is an evergreen map. It explains the difference between the two buckets, the criteria we use to prioritize research attention, and how to read the signals that matter most when a fast-growing private company starts to look and behave like a public one.

Bucket 1: Pre-IPO watchlist (we are tracking and evaluating)

Our pre-IPO watchlist is exactly what it sounds like: a set of late-stage private companies we are tracking and evaluating because they sit at the intersection of large addressable markets, credible execution, and a capital-markets path that could plausibly include a public listing. Importantly, “watchlist” does not imply ownership. It is a research posture: monitoring fundamentals, capital structure, investor composition, and market-clearing price discovery.

In practice, pre-IPO research tends to cluster around:

• Capital structure and funding cadence (primary rounds, secondaries, tender offers, and valuation step-ups/step-downs)
• Investor overlap (which long-only and crossover funds are consistently underwriting the theme)
• Unit-economics proxies (revenue run-rate disclosures, margins where visible, and customer concentration clues)
• Public-market analogs (comps, multiples, and the “public narrative” that will likely frame a future listing)
• Operational milestones that de-risk timing (facility buildouts, product launches, regulated approvals, scaling partnerships)

Recent examples of pre-IPO names we have written about illustrate the range of signals that can matter:

• AI infrastructure and compute names where valuation is increasingly tied to capex, customer concentration, and long-term supply contracts.
• Defense autonomy platforms where revenue visibility and program-of-record dynamics shape durability of growth.
• Deeptech (quantum-adjacent, photonics, specialty silicon) where the milestone is often “credible manufacturing” rather than pure model performance.

What we look for is not hype, but repeatable evidence: consistent investor sponsorship, a coherent pathway from private pricing to public comparables, and a narrative supported by milestones rather than slogans.

Bucket 2: Newchip warrants (warrants we hold via the Newchip portfolio)

The second bucket is different by design. Through the Newchip portfolio in the Frontier Alternatives Fund, we hold a set of equity warrants that can provide asymmetric upside if the underlying companies grow into meaningful outcomes. Here the work is less about daily price discovery and more about company-quality assessment: product, market positioning, capital needs, and the realism of the operating plan.

Because warrants are long-dated and outcomes are path-dependent, the research emphasis shifts toward:

• Business-model clarity (how the company makes money, who pays, and what repeatability looks like)
• Capital intensity and runway (how often the company may need to raise, and what dilution could look like)
• Distribution channels (partnerships, procurement, enterprise sales motion, or developer-led adoption)
• Category tailwinds (regulation, infrastructure buildout, or platform shifts that can accelerate adoption)

We treat these profiles as fundamental company write-ups. The goal is to understand the business and its potential trajectories, not to over-interpret short-term headlines.

How the two buckets connect (and why we keep them separate)

The two buckets are linked by a shared set of macro drivers: the cost of capital, the availability of late-stage growth equity, and the market’s appetite for new listings. But they behave differently.

Pre-IPO watchlist names are often sensitive to valuation marks, secondary liquidity, and shifts in public-market comps. When the market re-rates software multiples or compute infrastructure valuations, those signals can travel quickly into private pricing.

Warrant-backed companies can be less sensitive to daily market mood and more sensitive to execution risk: customer wins, product reliability, and the ability to raise follow-on capital on terms that keep the equity story intact.

Keeping the buckets separate helps us answer two different questions:

• “What is the market pricing right now?” (watchlist, secondary marks, and public comps)
• “What could this business become?” (warrant profiles, product/market fit, and capital needs)

A practical reading guide for the next 12 months

In the near term, we expect three recurring signal types to matter across Frontier Alternatives coverage:

• Secondary-market clearing prices for late-stage private names, which can act as a “shadow tape” for sentiment and liquidity.
• Large primary rounds that either validate a thesis (step-up valuation with strong sponsors) or reset expectations (flat/down rounds with structure).
• Milestone-driven de-risking (facility openings, scaled deployments, commercial partnerships) that make a future listing more credible.

We will continue to publish both kinds of insights pieces—watchlist updates and Newchip warrant profiles—using this map as the organizing spine.

Research-positioning takeaway

Frontier markets reward clarity. By separating watchlist research (tracking and evaluating pre-IPO names) from warrant research (warrants we hold via the Newchip portfolio), we can be precise about what each signal means, what it does not mean, and how it should inform an investor’s understanding of the private-to-public transition. Future company notes will link back to this framework so readers can interpret each update in context.